Bayesian Optimization of DBS for Gait
for Parkinson Disease (PD)
1 location in Minneapolis
Sponsor: University of Minnesota
Sex: All·Age: 18+
Code: NCT07835308·EARLY_Phase 1·Recruiting·Listed Sep 22, 2026
Clinical Trials at University of Minnesota
As of September 2026, 266 paid clinical trials are recruiting at University of Minnesota, located at MINNEAPOLIS VA MEDICAL CENTER, ONE VETERANS DRIVE, MINNEAPOLIS, MN 55417, phone (612) 725-2230 in Minneapolis, Minnesota. Active studies at this site cover conditions such as Heart Failure, Acute Myeloid Leukemia and Ovarian Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Minneapolis
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
for Symptomatic Genetic Dilated Cardiomyopathy (DCM)
Sites in Minneapolis, Rochester +26 more locations
Sponsor: Kardigan, Inc.
Sex: All·Age: 18+
Code: NCT07771465·Phase 3·Recruiting·Listed Aug 18, 2026
268 clinical trials at University of Minnesota
·Clear filters· Get a weekly email when new trials open in Minneapolis, MN.
Phase 2 Study to Assess the Safety and Efficacy of ANG003
for Exocrine Pancreatic Insufficiency (EPI)
Sites in Minneapolis +26 more locations
Sponsor: Anagram Therapeutics, Inc.
Sex: All·Age: 12+
Code: NCT07450547·Phase 2·Recruiting·Listed Mar 2026
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for Adenovirus Infections
Sites in Minneapolis +31 more locations
Sponsor: SymBio Pharmaceuticals
Sex: All·Age: 2 Months+
Code: NCT07387367·Phase 3·Recruiting·Listed Feb 2026
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
for Overweight
Sites in Minneapolis, Richfield +32 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 8 - 18
Code: NCT07253285·Phase 3·Recruiting·Listed Nov 2025
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
Drug: Olpasiran
Sites in Minneapolis, Saint Louis Park +192 more locations
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Drug: Amivantamab
Sites in Minneapolis, Rochester +123 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for Heart Failure With Preserved Ejection Fraction
Sites in Minneapolis, Maplewood +117 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07037459·Phase 3·Recruiting·Listed Jun 2025
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for Chronic Spontaneous Urticaria (CSU)
Drug: Remibrutinib
Sites in Minneapolis, Rochester +127 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06868212·Phase 3·Recruiting·Listed Mar 2025
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
for Interstitial Lung Diseases
Drug: Nerandomilast
Sites in Minneapolis, Rochester +29 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06806592·Phase 3·Recruiting·Listed Feb 2025
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for Acute Myeloid Leukemia (AML)
Sites in Minneapolis +41 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT07007312·Phase 3·Recruiting·Listed Jun 2025
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
for Cardiovascular Diseases
Sites in Minneapolis +46 more locations
Sponsor: BrioHealth Solutions, Inc.
Sex: All·Age: 18 - 100
Code: NCT06310031·Recruiting·Listed Mar 2024
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for Myelofibrosis
Sites in Minneapolis +29 more locations
Sponsor: Sumitomo Pharma America, Inc.
Sex: All·Age: 18+
Code: NCT04176198·Phase 1, Phase 2·Recruiting·Listed Nov 2019
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
for Sickle Cell Disease
Drug: Etavopivat
Sites in Minneapolis +43 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 12+
Code: NCT06612268·Phase 3·Recruiting·Listed Sep 2024
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
for Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Drug: Avacopan
Sites in Minneapolis, Rochester +56 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 100
Code: NCT06072482·Phase 4·Recruiting·Listed Oct 2023
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
for Type 1 Diabetes Mellitus
Sites in Minneapolis +44 more locations
Sponsor: COUR Pharmaceutical Development Company, Inc.
Sex: All·Age: 12 - 35
Code: NCT06783309·Phase 1, Phase 2·Recruiting·Listed Jan 2025
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for Superficial Bladder Cancer
Sites in Minneapolis, Rochester +46 more locations
Sponsor: enGene, Inc.
Sex: All·Age: 18+
Code: NCT04752722·Phase 1, Phase 2·Recruiting·Listed Feb 2021
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
for Pulmonary Hypertension
Sites in Minneapolis +36 more locations
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT06911632·Recruiting·Listed Apr 2025
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for Advanced Melanoma
Drug: Nivolumab
Sites in Minneapolis +43 more locations
Sponsor: Replimune, Inc.
Sex: All·Age: 12+
Code: NCT06264180·Phase 3·Recruiting·Listed Feb 2024
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
for Brain Tumor, Recurrent
Sites in Minneapolis +50 more locations
Sponsor: GT Medical Technologies, Inc.
Sex: All·Age: All ages
Code: NCT04427384·Recruiting·Listed Jun 2020
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
for Metastatic Non Small Cell Lung Cancer
Sites in Minneapolis +20 more locations
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All·Age: 18 - 70
Code: NCT04614103·Phase 2·Recruiting·Listed Nov 2020
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for Treatment Resistant Depression
Sites in Minneapolis +52 more locations
Sponsor: LivaNova
Sex: All·Age: 18+
Code: NCT03887715·Recruiting·Listed Mar 2019
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
for Heart Failure NYHA Class II
Sites in Minneapolis, Saint Cloud +43 more locations
Sponsor: Endotronix, Inc.
Sex: All·Age: 18+
Code: NCT05934487·Recruiting·Listed Jul 2023
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
for Aortic Stenosis
Drug: Pelacarsen
Sites in Minneapolis +32 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 50 - 80
Code: NCT05646381·Phase 2·Recruiting·Listed Dec 2022
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
for FSGS
Sites in Minneapolis +19 more locations
Sponsor: Dimerix Bioscience Pty Ltd
Sex: All·Age: 12 - 80
Code: NCT05183646·Phase 3·Recruiting·Listed Jan 2022
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
for Acute Myeloid Leukemia
Drug: Venetoclax
Sites in Minneapolis, Rochester +42 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT05735184·Phase 1·Recruiting·Listed Feb 2023
US National OCS Heart Perfusion (OHP) Registry
for Heart Transplant
Sites in Minneapolis, Rochester +35 more locations
Sponsor: TransMedics
Sex: All·Age: All ages
Code: NCT05915299·Recruiting·Listed Jun 2023
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for Epithelial Ovarian Cancer
Sites in Minneapolis, Rochester +24 more locations
Sponsor: TORL Biotherapeutics, LLC
Sex: Female·Age: 18+
Code: NCT06690775·Phase 2·Recruiting·Listed Nov 2024
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
for Spinal Muscular Atrophy (SMA)
Sites in Minneapolis +41 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: All ages
Code: NCT04174157·Recruiting·Listed Nov 2019
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
for Atherosclerosis
Sites in Minneapolis +22 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT07448038·Phase 2·Recruiting·Listed Mar 2026
A Gaucher Disease Gene Therapy Trial With FLT201
for Gaucher Disease Type 1
Sites in Minneapolis +15 more locations
Sponsor: Spur Therapeutics
Sex: All·Age: 18+
Code: NCT07223944·Phase 3·Recruiting·Listed Nov 2025
Diagnosing Epilepsy To EffeCT Change
for Epilepsy
Sites in Minneapolis, Rochester +19 more locations
Sponsor: Epiminder America, Inc.
Sex: All·Age: 18 - 75
Code: NCT07110337·Recruiting·Listed Aug 2025
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
for Ovarian Cancer
Sites in Minneapolis +16 more locations
Sponsor: Xencor, Inc.
Sex: All·Age: 15+
Code: NCT06276491·Phase 1·Recruiting·Listed Feb 2024
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
for Von Willebrand Disease (VWD)
Sites in Minneapolis +13 more locations
Sponsor: Vega Therapeutics, Inc
Sex: All·Age: 12 - 75
Code: NCT07115004·Phase 3·Recruiting·Listed Aug 2025
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
for Familial Pulmonary Fibrosis
Drug: Nerandomilast
Sites in Minneapolis +12 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 40+
Code: NCT07201922·Phase 3·Recruiting·Listed Oct 2025
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
for Prostatic Neoplasms
Sites in Minneapolis +11 more locations
Sponsor: Janssen Research & Development, LLC
Sex: Male·Age: 18+
Code: NCT06095089·Phase 1·Recruiting·Listed Oct 2023
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
for Candidemia
Sites in Minneapolis +21 more locations
Sponsor: Basilea Pharmaceutica
Sex: All·Age: 18+
Code: NCT05421858·Phase 3·Recruiting·Listed Jun 2022
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
for Systemic Lupus Erythematosus
Sites in Minneapolis +17 more locations
Sponsor: Cabaletta Bio
Sex: All·Age: 18 - 65
Code: NCT06121297·Phase 1, Phase 2·Recruiting·Listed Nov 2023
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
for Symptomatic Genetic Dilated Cardiomyopathy
Sites in Minneapolis, Rochester +26 more locations
Sponsor: Kardigan, Inc.
Sex: All·Age: 18+
Code: NCT07210723·Phase 2, Phase 3·Recruiting·Listed Oct 2025
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
for Non-Hodgkin Lymphoma
Sites in Minneapolis +9 more locations
Sponsor: Imugene Limited
Sex: All·Age: 18+
Code: NCT03666000·Phase 1·Recruiting·Listed Sep 2018
The Ailliance Post-Market Clinical Study
for Spinal Deformity
Sites in Minneapolis +21 more locations
Sponsor: Medtronic Spinal and Biologics
Sex: All·Age: 18+
Code: NCT05856370·Recruiting·Listed May 2023
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
for Focal Segmental Glomerulosclerosis
Sites in Minneapolis +9 more locations
Sponsor: Kaneka Medical America LLC
Sex: All·Age: Up to 21
Code: NCT02235857·Recruiting·Listed Sep 2014
Common conditions studied in Minneapolis
- Heart Failure (19 active studies)
- Acute Myeloid Leukemia (16 active studies)
- Ovarian Cancer (13 active studies)
- Coronary Artery Disease (12 active studies)
- Breast Cancer (11 active studies)
- Endometrial Cancer (11 active studies)
Leading research sponsors in Minneapolis
- University of Minnesota
- National Cancer Institute (NCI)
- Masonic Cancer Center, University of Minnesota
- VA Office of Research and Development
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Minneapolis?
There are approximately 898 recruiting clinical trials in Minneapolis, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Minneapolis pay participants?
Most recruiting trials in Minneapolis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Minneapolis?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Minneapolis?
The most common conditions under active study in Minneapolis include Heart Failure (19), Acute Myeloid Leukemia (16), Ovarian Cancer (13), Coronary Artery Disease (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Minneapolis?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Minneapolis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Minneapolis?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Minneapolis?
Recruiting research sites in Minneapolis include University of Minnesota, Abbott-Northwestern Hospital, Hennepin County Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Minneapolis right now?
The largest active categories in Minneapolis are Cancer & tumors (236), Cardiovascular (75), Neurology & pain (56). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Minnesota?
University of Minnesota is located at MINNEAPOLIS VA MEDICAL CENTER, ONE VETERANS DRIVE, MINNEAPOLIS, MN 55417. Use the Google Maps link in the intro above to get directions.
How do I contact University of Minnesota?
You can reach University of Minnesota by phone at (612) 725-2230. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in Minnesota
Rochester, MN(1,222)Saint Paul, MN(170)Saint Louis Park, MN(120)Edina, MN(112)Coon Rapids, MN(108)Duluth, MN(104)Maplewood, MN(82)Deer River, MN(68)Virginia, MN(68)Hibbing, MN(67)Sandstone, MN(66)Woodbury, MN(65)Burnsville, MN(63)Maple Grove, MN(59)Bemidji, MN(57)Brainerd, MN(55)Saint Cloud, MN(52)Shakopee, MN(47)Robbinsdale, MN(46)Waconia, MN(45)Stillwater, MN(43)Willmar, MN(37)Monticello, MN(35)New Ulm, MN(34)Mankato, MN(32)Princeton, MN(31)Wyoming, MN(30)Detroit Lakes, MN(28)Chaska, MN(25)Fosston, MN(24)Park Rapids, MN(23)Worthington, MN(21)Ely, MN(19)International Falls, MN(19)Moose Lake, MN(19)Thief River Falls, MN(19)Aitkin, MN(18)Baxter, MN(18)Cambridge, MN(16)Crosslake, MN(16)Pequot Lakes, MN(16)Pine River, MN(16)Staples, MN(16)Albert Lea, MN(14)Bloomington, MN(10)Marshall, MN(9)New Brighton, MN(9)Fridley, MN(7)Plymouth, MN(7)Alexandria, MN(6)Golden Valley, MN(6)Minneota, MN(6)Eden Prairie, MN(5)Minnetonka, MN(5)Dilworth, MN(4)Roseville, MN(4)Sartell, MN(4)Eagan, MN(3)Medina, MN(3)Richfield, MN(3)